Diabetes

Showing NaN - NaN of 60

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Recruiting
  • Diabetes
  • Type 2 Diabetes
  • Escondido, California
  • +128 more
Jan 18, 2023

Diabetes, Obesity Trial in United States (PF-06882961, Placebo)

Completed
  • Diabetes
  • Obesity
  • Phoenix, Arizona
  • +37 more
Nov 8, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, empagliflozin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +105 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +107 more
Jul 11, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +184 more
Jul 1, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +102 more
Jan 14, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Oct 26, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Glimepiride)

Completed
  • Diabetes
  • Birmingham, Alabama
  • +83 more
Jun 22, 2020

Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

Completed
  • Stroke
  • +2 more
  • Birmingham, Alabama
  • +182 more
Apr 14, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +116 more
Feb 14, 2020

Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of

Completed
  • Acute Ischemic Stroke
  • +2 more
  • IV insulin to maintain target glucose concentration of 80-130 mg/dL
  • Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
  • Tucson, Arizona
  • +69 more
Dec 13, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/insulin aspart
  • +2 more
  • Glendale, Arizona
  • +70 more
Nov 8, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +445 more
Jul 10, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec
  • +2 more
  • Little Rock, Arkansas
  • +80 more
Jun 3, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +145 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Faster-acting insulin aspart
  • +2 more
  • Mobile, Alabama
  • +190 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +85 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec/insulin aspart, insulin aspart, insulin detemir)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin degludec/insulin aspart
  • +2 more
  • Phoenix, Arizona
  • +72 more
Jun 3, 2019

Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Faster-acting insulin aspart
  • +2 more
  • Phoenix, Arizona
  • +154 more
May 22, 2019

Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, Diabetes Trial in Worldwide (ALN-PCSSC, Normal Saline)

Completed
  • Atherosclerotic Cardiovascular Disease
  • +2 more
  • Jacksonville, Florida
  • +53 more
Apr 23, 2019